New search | Conferencedetail
Print view
 
 

Allogeneic Cell Therapies Summit 2021

Evvnt Promotion / evvnt
-
17.05.2021 - 19.05.2021  Online
Time: 09:00 - 17:00
 
Conference themes
Patient-specific cell therapies have changed the face of cancer treatment, but with price points sky high and laborious manufacturing processes, this cure is out of reach for many patients.

The 3rd annual Allogeneic Cell Therapies Summit is the only industry-focused meeting dedicated to accelerating the clinical translation of allogeneic cell therapy, to provide an affordable and accessible treatment for patients globally.
Professional congress organizer (PCO)
Hanson Wade
Notes
Speakers: Sonny Hsiao, Founder and CEO, Acepodia, Nathan Yee, Associate Director, CMC Product Strategy, Allogeneic Cell Therapy, Bristol Myers Squibb, Joanna Brewer, SVP, Allogeneic Research, Adaptimmune and more
 

Enquiries and Registration:

https://go.evvnt.com/737980-1?pid=4832
Mr. Allogeneic Cell Therapies Team
 
Categories
Oncology
Languages
English
Congress fees
Drug Developers (Earlybird rates and bootcamp day available): USD 2299.0, Academic (Earlybird rates and bootcamp day available): USD 1799.0, Service Providers (Earlybird rates and bootcamp day available): USD 2699.0
Participants expected
250
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Ärztekammer für WienCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAlumni Club Medizinische Universität WienEuropean Health Forum GasteinHilfswerk AustriaEuropean Public Health Association (EUPHA)Österreichische Akademie der ÄrzteAnästhesie in Entwicklungsländern e. V.